Analysis of medaka cytochrome P450 3A homotropic and heterotropic cooperativity

被引：12

作者：

Kullman, SW ^{[1
]}

Kashiwada, S ^{[1
]}

Hinton, DE ^{[1
]}

机构：

[1] Duke Univ, Nicholas Sch Environm & Earth SCi, Durham, NC 27708 USA

来源：

MARINE ENVIRONMENTAL RESEARCH | 2004年 / 58卷 / 2-5期

关键词：

D O I：

10.1016/j.marenvres.2004.03.030

中图分类号：

X [环境科学、安全科学];

学科分类号：

08 ; 0830 ;

摘要：

We have previously demonstrated that medaka CYP3A is associated with metabolism of several endobiotics including steroids and bile acids. In this study, we demonstrate that medaka CYP3A catalysis exhibits unusual kinetic behaviors consistent with allosteric interaction which cannot be described by hyperbolic kinetic models. Using 7-benzyloxy-4-(trifluoromethyl)-coumarin (BFC) and nonylphenol as CYP3A substrates, we describe both homotropic and heterotropic cooperative interactions. Given the role of CYP3A in maintaining the homeostatic balance for numerous endobiotics, enzymatic activation/inhibition by endocrine disruptors (EDCs) represents a putative (non-genomic) mechanism for endocrine disruption. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：469 / 473

页数：5

共 50 条

[21] Significance of the minor cytochrome P450 3A isoforms
Daly, AK
CLINICAL PHARMACOKINETICS, 2006, 45 (01) : 13 - 31
[22] Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse
Tyden, E.
Olsen, L.
Tallkvist, J.
Tjalve, H.
Larsson, P.
RESEARCH IN VETERINARY SCIENCE, 2008, 85 (01) : 80 - 85
[23] THE HETEROTROPIC ACTIVATION OF THE MIDAZOLAM HYDROXYLASE ACTIVITY OF P450 3A BY A GPCR ALLOSTERIC MODULATOR
Blobaum, Anna
Bridges, Thomas
Byers, Frank W.
Mattmann, Margrith E.
Morrison, Ryan D.
Mackie, Claire
Bartolome, Jose M.
MacDonald, Gregor J.
Steckler, Thomas
Daniels, J. Scott
DRUG METABOLISM REVIEWS, 2012, 44 : 52 - 52
[24] Interaction of cytochrome P450 3A inhibitors with P-glycoprotein
Yasuda, K
Lan, LB
Sanglard, D
Furuya, K
Schuetz, JD
Schuetz, EG
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (01) : 323 - 332
[25] Exploring Alphanapthoflavone heterotropic allosteric regulation of Cytochrome P450 3A4
Woods, Caleb M.
Atkins, William M.
Fernandez, Cristina
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[26] Cytochrome P450 3A polymorphisms and immunosuppressive drugs:: an update
Anglicheau, Dany
Legendre, Christophe
Beaune, Philippe
Thervet, Eric
PHARMACOGENOMICS, 2007, 8 (07) : 835 - 849
[27] Cloning, expression, and characterization of cytochrome P450 3A in minipig
Soucek, P
Anzenbacher, P
Zuber, R
Anzenbacherová, E
Guengerich, FP
TOXICOLOGY, 2001, 164 (1-3) : 146 - 146
[28] Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
Roberts, Jessica K.
Moore, Chad D.
Ward, Robert M.
Yost, Garold S.
Reilly, Christopher A.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (02) : 308 - 316
[29] Cytochrome P450 3A pharmacogenetics: the road that needs traveled
D A Flockhart
J M Rae
The Pharmacogenomics Journal, 2003, 3 : 3 - 5
[30] Cooperativity in oxidations catalyzed by cytochrome P450 3A4
Ueng, YF
Kuwabara, T
Chun, YJ
Guengerich, FP
BIOCHEMISTRY, 1997, 36 (02) : 370 - 381

← 1 2 3 4 5 →